NCT04583475
Real-life Study of How to Intensify Treatment With Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria No drug interventions Not Available Not Available recruiting NCT06604949
A Study of Single Dose of LP-003 in Healthy Adult Subjects No drug interventions treatment 1 not_yet_recruiting NCT05513001
An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib treatment 3 active_not_recruiting NCT05528861
A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria treatment 2 terminated NCT05677451
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up treatment 3 recruiting NCT05936567
Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria treatment 2 recruiting NCT05960708
A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases treatment 1 completed NCT06042478
Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension. treatment 3 recruiting NCT06072157
Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria No drug interventions treatment 1 recruiting NCT06365879
To Compare Efficacy and Safety of CMAB007 and Xolair® in Patients With Chronic Spontaneous Urticaria treatment 3 recruiting NCT06445023
A Phase 3 Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria treatment 3 recruiting NCT06455202
A Phase 3 Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria (CSU) treatment 3 recruiting NCT06577116
Open-Label Extension Study for Subjects With H1 Antihistamine Refractory Chronic Spontaneous Urticaria Completing Study AK006-001 No drug interventions treatment 1 enrolling_by_invitation NCT05526521
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) (LIBERTY-CSU CUPIDKids) treatment 3 recruiting NCT04944602
Study to Evaluate the Therapeutic Equivalence of SYN008 Versus Xolair® in the Treatment of Patients With Refractory Chronic Spontaneous Urticaria treatment 3 unknown_status NCT06295302
A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria No drug interventions treatment 2 recruiting NCT03328897
Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria treatment 3 completed NCT06162728
Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU) treatment 1 / 2 recruiting NCT05030311
A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines treatment 3 completed NCT03437278
Study to Investigate the Efficacy and Safety of QGE031 in Adolescent Patients With Chronic Spontaneous Urticaria (CSU) treatment 2 completed NCT03907878
A Safety and Efficacy Study of Ligelizumab in the Treatment of CSU in Japanese Patients Inadequately Controlled With H1- Antihistamines treatment 3 completed NCT04180488
Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID) treatment 3 active_not_recruiting NCT06294288
A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants No drug interventions treatment 1 active_not_recruiting NCT03580356
A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines. treatment 3 completed NCT05368285
A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria treatment 2 active_not_recruiting NCT05298215
A Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Efficacy of UB-221 IV Infusion as an add-on Therapy in Patients With Chronic Spontaneous Urticaria No drug interventions treatment 2 recruiting NCT02477332
Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU treatment 2 completed NCT06250400
Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU) treatment 4 not_yet_recruiting NCT05048342
A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistamines treatment 3 completed NCT04314999
Frequency of Parasite Infestation in Patients With Chronic Spontaneous Urticaria No drug interventions Not Available Not Available completed NCT05335499
A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous Urticaria No drug interventions treatment 2 completed NCT02550106
Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment treatment 4 completed NCT01803763
Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients basic_science 2 / 3 completed NCT03789422
Tranexamic Acid and Spontaneous Chronic Urticaria treatment 4 unknown_status NCT05032157
A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1- Antihistamines treatment 3 completed NCT03661866
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC No drug interventions Not Available Not Available recruiting NCT04444466
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UCB8600 in Healthy Participants, Atopic Participants, and Chronic Spontaneous Urticaria Participants No drug interventions basic_science 1 terminated NCT06053801
A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China No drug interventions Not Available Not Available recruiting NCT02372604
Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria treatment 3 completed NCT01723072
Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy treatment 3 completed NCT06108869
Improving Health and Wellbeing for People Diagnosed With Chronic Spontaneous Urticaria (CSU) No drug interventions other Not Available suspended NCT03494881
Mepolizumab for the Treatment of Chronic Spontaneous Urticaria treatment 0 active_not_recruiting NCT05373355
Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria. No drug interventions other 1 completed NCT04439955
Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol (CBD) as a Steroid-sparing Therapy in Chronic Spontaneous Urticaria (CSU) Patients treatment 2 completed NCT04426890
To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria treatment 3 completed NCT05992987
Assessment of Serum Levels of Adenosine Deaminase and Immunoglobulin E in Patients With Chronic Spontaneous Urticaria No drug interventions Not Available Not Available not_yet_recruiting NCT05795153
A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks. treatment 3 completed NCT05169645
STOP CSUA: phySical acTivity, mOod and sleeP in Chronic Spontaneous Urticaria and Angioedema No drug interventions Not Available Not Available unknown_status NCT03926611
This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines No drug interventions treatment 2 completed NCT05107115
Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine treatment 2 completed NCT05916937
Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria treatment 4 recruiting NCT04109313
An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSU No drug interventions treatment 2 completed NCT04903613
Global Managed Access Program Cohort for Ligelizumab in CSU Not Available Not Available no_longer_available NCT02649218
A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients treatment 2 completed NCT06509334
Trial of JYB1904 in Chronic Spontaneous Urticaria. treatment 2 not_yet_recruiting NCT05170724
Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous Urticaria Not Available Not Available available NCT03749135
Dupilumab in Chronic Spontaneous Urticaria treatment 2 completed NCT04612725
A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO) treatment 2 terminated NCT04513548
Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria basic_science 1 terminated NCT06396026
A Study of Efficacy and Safety of TLL-018 in CSU Participants No drug interventions treatment 3 not_yet_recruiting NCT06077773
Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria No drug interventions treatment 2 recruiting NCT06228560
Efficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment treatment 2 recruiting NCT04538794
A Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria treatment 1 completed NCT02161562
OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients treatment 3 completed NCT04893980
Efficacy of Low-dose Interleukin-2 Treatment in Chronic Spontaneous Urticaria treatment 2 / 3 unknown_status NCT04827589
Study to Evaluate the Efficacy, Safety, and Tolerability of Tirabrutinib in Participants With Antihistamine-Resistant Chronic Spontaneous Urticaria treatment 2 withdrawn NCT04159701
A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria No drug interventions treatment 2 terminated NCT03580369
A Phase III Study of Safety and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines treatment 3 completed NCT04833855
Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria treatment 2 completed NCT04404023
Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of UB-221 in Healthy Volunteers No drug interventions treatment 1 not_yet_recruiting NCT05129423
A Study of MTPS9579A in Participants With Refractory Chronic Spontaneous Urticaria No drug interventions treatment 2 withdrawn NCT04210323
Shotblocker® Use in Subcutaneous Injection No drug interventions supportive_care Not Available completed NCT04210843
Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab treatment 3 terminated